Back to UBS Group AG UBS Group AG

EVMNEVMN
3 quarters

Position history for UBS Group AGUBS Group AG's holdings in EVOMMUNE INC

Yes. Ubs holds 413,553 shares of EVMN (Evommune), worth $5.5M, as of its Q2 2026 13F filing. It increased the position by 115,178 shares (+38.6%) from Q1 2026. Ubs has held EVMN in every 13F on record since Q4 2025, 3 quarterly filings.

Current Value

$5.5M

Current Shares

413,553

Total Value Change

+$5.4M

Total Shares Change

+410,139

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
413,553
+38.6%
$5.5M0.0%$13.29
36
2026-Q1
Increased
298,375
+8639.8%
$6.9M0.0%$22.99
44
2025-Q4
New
3,414
-
$58,4480.0%$17.12
32

Other major holders of EVMN: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used